ACTA1 and familial pancreatic carcinoma: On the other hand, Sinn et al., in 162 patients after radical pancreatic cancer surgery, found strong αSMA protein expression in 46 (29%), moderate in 87 (54%) and weak in 25 (16%) patients [26].